Moreover, forced IGF1 signaling partially reversed the migratory propensity of NECTIN1-deficient cells in the modified transwell assay in 6 different human melanoma cell lines (Fig. 7d), similar to direct treatment with IGF1 itself (Fig. 7e). This evidence concerns the gene NECTIN1 and melanoma.